Q2 2024 Holdings
Filed 2024-08-13 | 266 holdings | $529.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $55.6M | 1,603,932 | 10.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $46.3M | 853,862 | 8.7% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $43.9M | 4,150,009 | 8.3% |
| EA Series Trust(BOXX) | ALPHA ARCH 1-3 | 02072L565 | $37.9M | 351,482 | 7.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $32.0M | 1,264,570 | 6.0% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $31.2M | 1,181,332 | 5.9% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $25.1M | 548,916 | 4.7% |
| Insmed Inc(INSM)Put | COM PAR $.01 | 457669307 | $13.5M | 200,800 | 2.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $12.6M | 476,543 | 2.4% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $10.2M | 3,289,260 | 1.9% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $10.1M | 150,000 | 1.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $9.4M | 75,750 | 1.8% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $8.9M | 2,063,962 | 1.7% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $8.1M | 1,420,422 | 1.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $7.9M | 436,608 | 1.5% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.5M | 750,000 | 1.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $7.0M | 51,263 | 1.3% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $5.9M | 356,878 | 1.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $5.5M | 1,222,676 | 1.0% |
| Absci Corporation(ABSI) | COM | 00091E109 | $5.2M | 1,698,529 | 1.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $4.8M | 91,227 | 0.9% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $4.7M | 196,577 | 0.9% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $4.4M | 8,000 | 0.8% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $4.1M | 404,138 | 0.8% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $3.9M | 155,799 | 0.7% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $3.8M | 93,350 | 0.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $3.4M | 74,850 | 0.6% |
| Spdr SER TR(BIL) | BLOOMBERG 1-3 MO | 78468R663 | $3.0M | 32,500 | 0.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $2.8M | 42,217 | 0.5% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $2.8M | 156,504 | 0.5% |
| Acasti Pharma Inc | CL A | 00430K865 | $2.8M | 959,571 | 0.5% |
| Vanguard BD Index FDS(VUSB) | VANGUARD ULTRA | 92203C303 | $2.7M | 55,206 | 0.5% |
| J P Morgan Exchange Traded F(JPST) | ULTRA SHRT INC | 46641Q837 | $2.7M | 54,000 | 0.5% |
| Ishares TR(SHV) | SHORT TREAS BD | 464288679 | $2.7M | 24,500 | 0.5% |
| Savara Inc(SVRA) | COM | 805111101 | $2.7M | 663,598 | 0.5% |
| Omniab Inc(OABI) | COM | 68218J103 | $2.7M | 712,560 | 0.5% |
| Wisdomtree TR(USFR) | FLOATNG RAT TREA | 97717Y527 | $2.7M | 53,000 | 0.5% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $2.5M | 542,233 | 0.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.3M | 253,197 | 0.4% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $2.3M | 368,369 | 0.4% |
| Kala BIO Inc(KALA) | COM NEW | 483119202 | $2.2M | 306,067 | 0.4% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $2.1M | 114,309 | 0.4% |
| Cerevel Therapeutics Hldng I(CERE1EUR)Put | COM | 15678U128 | $2.1M | 50,200 | 0.4% |
| SSgA Active ETF TR(ULST) | ULT SHT TRM BD | 78467V707 | $1.9M | 47,684 | 0.4% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $1.7M | 72,800 | 0.3% |
| Cellectar Biosciences Inc(CLRBUSD) | COM NEW | 15117F807 | $1.7M | 682,094 | 0.3% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $1.7M | 103,121 | 0.3% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $1.7M | 198,347 | 0.3% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $1.6M | 39,929 | 0.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $1.6M | 40,875 | 0.3% |